Cargando…
IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine
Ketamine, an N-methyl-D-aspartate receptor antagonist, exerts rapid and sustained antidepressant actions. Preclinical studies demonstrated that the release of brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor in the medial prefrontal cortex (mPFC) is essential for the a...
Autores principales: | Deyama, Satoshi, Kondo, Makoto, Shimada, Shoichi, Kaneda, Katsuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110717/ https://www.ncbi.nlm.nih.gov/pubmed/35577782 http://dx.doi.org/10.1038/s41398-022-01943-9 |
Ejemplares similares
-
Noradrenergic stimulation of α(1) adrenoceptors in the medial prefrontal cortex mediates acute stress-induced facilitation of seizures in mice
por: Niitani, Kazuhei, et al.
Publicado: (2023) -
The endogenous opioid system in the medial prefrontal cortex mediates ketamine’s antidepressant-like actions
por: Pittenger, Christopher, et al.
Publicado: (2023) -
Role of 5-HT(1A) Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine
por: Fukumoto, Kenichi, et al.
Publicado: (2017) -
Higher glutamatergic activity in the medial prefrontal cortex in chronic ketamine users
por: Wu, Qiuxia, et al.
Publicado: (2022) -
Noradrenaline enhances the excitatory effects of dopamine on medial prefrontal cortex pyramidal neurons in rats
por: Shinohara, Fumiya, et al.
Publicado: (2020)